OTHR-16. CONCURRENT USE OF APREPITANT AND IFOSFAMIDE IN PEDIATRIC CANCER PATIENTS

BACKGROUND: Aprepitant, a selective neurokinin-1 receptor antagonist, is commonly used for prevention of chemotherapy-induced nausea and vomiting. Its use with ifosfamide is controversial due to the putative risk of potentiating neurotoxicity via inhibition of cytochrome P450 3A4 (CYP3A4). The curre...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Winzent, Shelby, Dahl, Nathan, Hemenway, Molly, Lovria, Rachel, Dorris, Kathleen
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2020
Onderwerpen:
Others (Not Fitting Any Other Category)
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715537/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.637
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items